Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Hold
1,343
0.04% 185
2026
Q1
$473K Hold
1,343
0.04% 171
2025
Q4
$440K Buy
1,343
+183
+16% +$58K 0.04% 164
2025
Q3
$327K Hold
1,160
0.03% 138
2025
Q2
$324K Hold
1,160
0.03% 135
2025
Q1
$361K Hold
1,160
0.04% 128
2024
Q4
$302K Buy
1,160
+217
+23% +$64.4K 0.04% 133
2024
Q3
$304K Buy
943
+74
+9% +$24.2K 0.04% 129
2024
Q2
$272K Buy
869
+8
+0.9% +$2.35K 0.03% 133
2024
Q1
$245K Buy
861
+36
+4% +$10.5K 0.03% 138
2023
Q4
$238K Sell
825
-183
-18% -$49.9K 0.04% 131
2023
Q3
$271K Buy
1,008
+50
+5% +$12.5K 0.05% 112
2023
Q2
$213K Buy
+958
New +$222K 0.04% 124
2023
Q1
Sell
-797
Closed -$209K 130
2022
Q4
$209K Buy
+797
New +$214K 0.04% 115
2021
Q2
Sell
-813
Closed -$202K 111
2021
Q1
$202K Buy
+813
New +$194K 0.05% 99
2020
Q4
Sell
-788
Closed -$200K 102
2020
Q3
$200K Buy
+788
New +$195K 0.06% 90
2018
Q2
Sell
-2,539
Closed -$433K 95
2018
Q1
$433K Sell
2,539
-230
-8% -$42.2K 0.12% 57
2017
Q4
$482K Buy
2,769
+64
+2% +$11.3K 0.12% 55
2017
Q3
$504K Buy
2,705
+305
+13% +$54K 0.13% 54
2017
Q2
$413K Hold
2,400
0.11% 57
2017
Q1
$394K Sell
2,400
-850
-26% -$141K 0.11% 54
2016
Q4
$475K Buy
+3,250
New +$489K 0.14% 43
2016
Q3
Sell
-5,853
Closed -$891K 77
2016
Q2
$891K Buy
+5,853
New +$910K 0.31% 35
2015
Q3
Sell
-1,410
Closed -$216K 78
2015
Q2
$216K Buy
+1,410
New +$226K 0.05% 107

Other funds holding AMGN

KLCM Advisors's AMGN Position: Q2 2026 in Review

KLCM Advisors held its Amgen (AMGN) position steady in Q2 2026 at 1,343 shares worth $486K. The position accounts for 0.04% of the portfolio, ranked #185.

KLCM Advisors first reported a position in AMGN in Q2 2015 and has held it in 24 quarters since. The position peaked at $891K in Q2 2016. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • KLCM Advisors held 1,343 shares of Amgen worth $486K as of Q2 2026.
  • KLCM Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.04% of KLCM Advisors's portfolio in Q2 2026, its #185 holding.
  • KLCM Advisors first reported a position in Amgen in Q2 2015 and has held it in 24 quarters since.
  • KLCM Advisors's Amgen position peaked at $891K in Q2 2016.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.